SynthesisCPT: pharmacometrics & systems pharmacology2026

Exposure-Efficacy Meta-Model of Nintedanib in Adult Patients With Chronic Fibrosing Interstitial Lung Diseases.

Sonja Hartmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.